SARS-CoV-2 Reinfection Rate: A Systematic Review and Meta-analysis

Y. Alimohamadi, Kiana Bahani, Kolsoom Alimohammadi, M. Sepandi
{"title":"SARS-CoV-2 Reinfection Rate: A Systematic Review and Meta-analysis","authors":"Y. Alimohamadi, Kiana Bahani, Kolsoom Alimohammadi, M. Sepandi","doi":"10.52547/iem.9.1.63","DOIUrl":null,"url":null,"abstract":"Backgrounds: Reinfection among COVID-19 patients is still a challenging issue in the medical literature. Therefore, the current meta-analysis was conducted to estimate the pooled incidence rate of reinfection among COVID-19 patients. Material(s) and Method(s): A comprehensive search was conducted in PubMed, Web of Science, and Scopus databases from July 1 to October 1, 2021. Original studies which estimated the incidence rate of COVID-19 reinfection were included. CASP (Critical Appraisal skills program) was used to assess the quality of studies. Data were analyzed by STATA statistical software Version 15 (StataCorp, College Station, TX, USA). Finding(s): A total of 3803 articles were found, of which 16 articles remained after title, , and full text screening. The minimum and maximum incidence rates of reinfection were 0.001 and 0.73%, respectively. The pooled estimated incidence rate of COVID-19 reinfection was 0.11% (95% confidence interval: 0.02-0.20, p< .001, I2 = 100.0). The highest pooled estimated incidence rate of reinfection was observed in people <50 years old (0.14%) (95% CI: 0.001-0.34, p<.001, I2 = 100). Regarding the time elapsed after the first infection, the highest reinfection rate occurred four months after the first infection (0.12%) (95% CI: 0.001-0.27, p< .001, I2 = 100). Conclusion(s): The incidence rate of reinfection among COVID-19 patients is expected to be high. However, it seems that the influence of factors including the age of patients and the time elapsed after the first infection must be considered.Copyright A© 2023, TMU Press.","PeriodicalId":34545,"journal":{"name":"Infection Epidemiology and Microbiology","volume":"177 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Epidemiology and Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/iem.9.1.63","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Backgrounds: Reinfection among COVID-19 patients is still a challenging issue in the medical literature. Therefore, the current meta-analysis was conducted to estimate the pooled incidence rate of reinfection among COVID-19 patients. Material(s) and Method(s): A comprehensive search was conducted in PubMed, Web of Science, and Scopus databases from July 1 to October 1, 2021. Original studies which estimated the incidence rate of COVID-19 reinfection were included. CASP (Critical Appraisal skills program) was used to assess the quality of studies. Data were analyzed by STATA statistical software Version 15 (StataCorp, College Station, TX, USA). Finding(s): A total of 3803 articles were found, of which 16 articles remained after title, , and full text screening. The minimum and maximum incidence rates of reinfection were 0.001 and 0.73%, respectively. The pooled estimated incidence rate of COVID-19 reinfection was 0.11% (95% confidence interval: 0.02-0.20, p< .001, I2 = 100.0). The highest pooled estimated incidence rate of reinfection was observed in people <50 years old (0.14%) (95% CI: 0.001-0.34, p<.001, I2 = 100). Regarding the time elapsed after the first infection, the highest reinfection rate occurred four months after the first infection (0.12%) (95% CI: 0.001-0.27, p< .001, I2 = 100). Conclusion(s): The incidence rate of reinfection among COVID-19 patients is expected to be high. However, it seems that the influence of factors including the age of patients and the time elapsed after the first infection must be considered.Copyright A© 2023, TMU Press.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SARS-CoV-2再感染率:系统回顾和meta分析
背景:在医学文献中,COVID-19患者的再感染仍然是一个具有挑战性的问题。因此,本荟萃分析旨在估计COVID-19患者再感染的合并发生率。材料和方法:综合检索PubMed、Web of Science和Scopus数据库,检索时间为2021年7月1日至10月1日。纳入了估计COVID-19再感染发生率的原始研究。CASP(批判性评估技能计划)用于评估研究的质量。数据采用STATA统计软件Version 15 (StataCorp, College Station, TX, USA)进行分析。结果:共发现3803篇文章,经标题、全文筛选后,剩余16篇文章。再感染的最小和最大发生率分别为0.001和0.73%。合并估计的COVID-19再感染发生率为0.11%(95%可信区间:0.02 ~ 0.20,p< 0.001, I2 = 100.0)。再感染的合并估计发生率最高的人群是50岁以下(0.14%)(95% CI: 0.001-0.34, p<。001, i2 = 100)。再感染率在首次感染后4个月内最高(0.12%)(95% CI: 0.001 ~ 0.27, p< 0.001, I2 = 100)。结论:2019冠状病毒病患者再感染发生率较高。然而,似乎必须考虑患者年龄和首次感染后的时间等因素的影响。版权所有©2023,TMU出版社。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
20
审稿时长
6 weeks
期刊最新文献
Tracing the Origin and Early Progression of COVID-19 in Europe: An Epidemiological Descriptive Study Exploring Antibiotic Susceptibility in Otomycosis: Uncovering Mixed Infections of Fungal and Bacterial Origin in Indonesia Antimicrobial Activity of Traditional Medicinal Plant Extracts against Bacterial and Fungal Strains Causing Dental Caries: An in Vitro Study Prevalence of Extended-Spectrum B-Lactamase (ESBL) and Quinolone Resistance (qnr) Genes among Cytotoxic Necrotizing Factor-1-Producing Uropathogenic Escherichia coli in Babylon, Iraq Association between Torque Teno Virus Frequency and Systemic Lupus Erythematosus: A Potential Trigger for Autoimmune Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1